CSPC PHARMA (01093.HK) has initiated a Phase II clinical trial in China of SYS-6026 injection for treatment of HPV16/18‑related high-grade cervical squamous intraepithelial lesions.

2026-07-22

CSPC PHARMA (01093.HK) has initiated a Phase II clinical trial in China of SYS-6026 injection for treatment of HPV16/18‑related high-grade cervical squamous intraepithelial lesions.

Other News
2026-07-22

Sources indicate that the Trump administration will submit a nuclear energy agreement with Saudi Arabia to Congress in the coming days, an agreement that lacks safeguards.

2026-07-22

Trump is imposing new tariffs on Canadian exports based on a legal provision that has never been invoked since legislation in 1930. The new tariffs are based on Section 338 of the U.S. Tariff Act of 1930, which targets "discriminatory practices by fo